Quick Search:         Advanced Search
Chinese Version
Online office
Journal Online
Download
Top
Links
黄培新,黄燕,卢明,杜宝新,梁伟雄,欧爱华,蔡业峰,郭建文,奚肇庆,陈眉,董少龙,陆晖,李军,东贵荣,李海聪,赵建军,刘茂才.急性脑出血中西医结合综合治疗方案研究[J].,2006,(7):590-593
急性脑出血中西医结合综合治疗方案研究
Treatment of Acute Intracerebral Hemorrhage with a Comprehensive Protocol of Integrated Chinese and Western Medicine
  
DOI:
中文关键词:  急性脑出血  多中心临床试验  中西医结合综合治疗方案
英文关键词:acute intracerebral hemorrhage  multi-center clinical trial  comprehensi ve protocol of integrated Chinese and Western medicine
基金项目:国家科技十五攻关课题(No.2001BA701A12b);国家中医药管理局课题(No.02-03LQ006);广东省科技计划项目(No2002C30602)
Author NameAffiliation
HUANG Pei-xin 广东省中医院神经一科 
HUANG Yan 广东省中医院神经一科 
LU Ming 广东省中医院神经一科 
杜宝新 广东省中医院神经一科 
梁伟雄 广东省中医院神经一科 
欧爱华 广东省中医院神经一科 
蔡业峰 广东省中医院神经一科 
郭建文 广东省中医院神经一科 
奚肇庆 江苏省中医院 
陈眉 浙江省中医院 
董少龙 广西中医学院第一附属医院 
陆晖 广西中医学院附属瑞康医院 
李军 陕西中医学院附属医院 
东贵荣 黑龙江中医药大学第二附属医院 
李海聪 北京中日友好医院 
赵建军 长春中医学院附属医院 
刘茂才 广东省中医院神经一科 
Hits: 1487
Download times: 6
中文摘要:
      目的观察中西医结合综合方案治疗急性脑出血的疗效。方法采用多中心、单盲随机对照试验的设计方法,404例患者分别用中西医结合综合(结合组199例)和西医加中药安慰剂(对照组205例)治疗,并观察相关指标。结果与对照组比较,结合组患者治疗后28天和90天时神经功能缺损评分均改善(P<0·05);90天严重致残加病死率(BI<75)降低(P<0·05);90天完全康复和轻微残疾率(BI≥95)提高(P<0·05);90天社会功能活动(FAQ)改善(P<0·01)。不良反应为非感染性腹泻(发生率为5·53%)。结论中西医结合综合治疗方案可改善本病患者90天的神经功能和生活质量,降低严重致残+病死率;其不良反应主要为非感染性腹泻。
英文摘要:
      ObjectiveTo observe the effect and safety o f a comprehensive protoco l of integrated Chinese and Western medicine (ICWM) in treating acute intracereb ral h emorrhage (AICH). MethodsA multi-center, single blin ded, random and control cl inical trial was adopted with 404 patients with AICH, they were divided into the treatment group (199 cases) treated with ICWM protocol, and the control group (2 05 cases) treated with Western medicine plus placebo, and AICH related inde xes were assessed after treatment. ResultsCompared with the control group, the neurological deficit score (National Institute of Health Stroke Scale, NIHSS) determined on the 28th and the 90th day after treatment was ameliorated in the t reatment group (P<0.01). Moreover, the 90th day assessment sho wed that the mortali ty and severe disability rate was lower (BI<75) (P<0.05), the complete rehabili tation and mild disability rate (BI ≥ 95,P<0.05), and the s ociability rate (F unctional Assessment Questionnaire,FAQ) were higher (P<0.01 ) in the treatment g roup than those in the control group. The incidence of adverse reaction was 5 . 53%, manifested as non-infective diarrhea. ConclusionT he ICWM protocol used in this study may improve neural function and quality of life of AICH patient s, and reduce the mortality and severe disability rate in those after 90 days’ t reatment, with only non-infective diarrhea as the adverse reaction.
View Full Text  View/Add Comment  Download reader